Joint (JYNT) Research & Development (2013 - 2026)
Joint (JYNT) posted Research & Development of $3.7 million for Q1 2026, up 6.37% sequentially from $3.5 million in Q4 2025, and up 6.04% YoY from $3.5 million in Q1 2025.
Joint (JYNT) Research & Development (2013 - 2026) Analysis & Trends
Joint has reported Research & Development for 14 years, with the latest figure at $3.7 million in Q1 2026.
- Quarterly Research & Development rose 6.04% year-over-year to $3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.5 million (up 10.37% YoY) and the FY2025 annual result came in at $13.3 million, up 21.19% from the prior year.
- Research & Development climbed to $3.7 million in Q1 2026 per JYNT's latest filing, from $3.5 million in the prior quarter.
- Over five years, Research & Development peaked at $3.8 million in Q2 2022 and troughed at $307110.0 in Q4 2022.
- A 5-year average of $2.8 million and a median of $2.8 million in 2025 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2023: Research & Development tumbled 89.49% in 2022, then soared 441.75% in 2023.
- Over 5 years, Research & Development stood at $307110.0 in 2022, then jumped by 441.75% to $1.7 million in 2023, then surged by 67.78% to $2.8 million in 2024, then advanced by 25.18% to $3.5 million in 2025, then advanced by 6.37% to $3.7 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered $3.7 million, $3.5 million, and $2.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | - |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | - |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | - |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | - |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | - |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | - |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | - |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | - |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | - |
| 10 | Joint | 119.99 Mn | 97.85 Mn | 12.70 Mn | 4.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.89 Mn |
| Mar 31, 2026 | 3.72 Mn |
| Dec 31, 2025 | 3.49 Mn |
| Sep 30, 2025 | 2.82 Mn |
| Jun 30, 2025 | 3.48 Mn |
| Mar 31, 2025 | 3.51 Mn |
| Dec 31, 2024 | 2.79 Mn |
| Sep 30, 2024 | 2.50 Mn |
| Jun 30, 2024 | 3.44 Mn |
| Mar 31, 2024 | 2.24 Mn |
| Dec 31, 2023 | 1.66 Mn |
| Sep 30, 2023 | 2.24 Mn |
| Jun 30, 2023 | 2.47 Mn |
| Mar 31, 2023 | 2.32 Mn |
| Dec 31, 2022 | 307,110.00 |
| Sep 30, 2022 | 3.54 Mn |
| Jun 30, 2022 | 3.84 Mn |
| Mar 31, 2022 | 3.29 Mn |
| Dec 31, 2021 | 2.92 Mn |
| Sep 30, 2021 | 2.88 Mn |